pfizer glp-1 drug China has approved Pfizer's treatment Xianweiying for long-term weight management in overweight or obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market Pfizer's embattled obesity program loses
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20










:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)















